Evome Medical Technologies (Evome Medical Technologies) COGS-to-Revenue : 0.65 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies COGS-to-Revenue?

Evome Medical Technologies's Cost of Goods Sold for the three months ended in Dec. 2023 was $7.59 Mil. Its Revenue for the three months ended in Dec. 2023 was $11.72 Mil.

Evome Medical Technologies's COGS to Revenue for the three months ended in Dec. 2023 was 0.65.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Evome Medical Technologies's Gross Margin % for the three months ended in Dec. 2023 was 35.22%.

Evome Medical Technologies COGS-to-Revenue Historical Data

The historical data trend for Evome Medical Technologies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies COGS-to-Revenue Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.05

0.67

0.64

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.67	0.62	0.66	0.63	0.65

Evome Medical Technologies COGS-to-Revenue Calculation

Evome Medical Technologies's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	29.885	/	46.681
	=	0.64

Evome Medical Technologies's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.592	/	11.719
	=	0.65

Evome Medical Technologies (OTCPK:LNDZF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Evome Medical Technologies's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	7.592 / 11.719
	=	35.22 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Evome Medical Technologies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.